Notice: Confirmation of the Mandatory use of the Regulatory Enrolment Process (REP) as of October 1, 2020

By way of this update, Health Products and Food Branch (HPFB) is reminding sponsors that the mandatory date for use of the Regulatory Enrolment Process (REP) and the Common Electronic Submissions Gateway (CESG) is October 1, 2020 applicable to pharmaceutical, biologic and radiopharmaceutical drugs for human use as well as disinfectants, pursuant to Part C, Division 1 and Division 8 of the Food and Drug Regulations.

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 17:29 (UTC)
Created	April 17, 2026, 17:29 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2020-10-20 00:00:00
open_canada_keywords	{"fr": ["avis", "utilisation obligatoire", "processus d'inscription réglementaire", "REP", "passerelle commune de présentation électronique", "SCEE", "médicaments pharmaceutiques et biologiques", "médicaments radiopharmaceutiques", "médicaments à usage humain"], "en": ["notice", "mandatory use", "regulatory enrolment process", "REP", "common electronic submissions gateway", "CESG", "pharmaceutical-and-biologic drugs", "radiopharmaceutical drugs", "drugs for human-use"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Avis: Confirmation de l’utilisation obligatoire du processus d’inscription réglementaire (RIP) à partir du 1er octobre 2020
update_frequency	as_needed